Nexalin Technology (NXL) Gross Margin (2021 - 2026)
Nexalin Technology (NXL) posted Gross Margin of 73.16% for Q2 2026, down 16.72% on a QoQ basis from 87.85% in Q1 2026, and up 551.0% year-over-year from 11.24% in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Gross Margin (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Gross Margin for 6 years, with the latest figure at 73.16% in Q2 2026.
- On a quarterly basis, Gross Margin rose 551.0% year-over-year to 73.16% in Q2 2026; TTM through Jun 2026 was 86.16%, a 1853.0% increase from a year earlier, with the FY2025 full-year figure at 79.65%, up 134.0% from the prior year.
- Gross Margin was 73.16% for Q2 2026 at Nexalin Technology, down from 87.85% in the prior quarter.
- The five-year high for Gross Margin was 88.36% in Q1 2024, with the low at 64.77% in Q3 2024.
- Average Gross Margin over 5 years is 76.25%, with a median of 74.08% recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Gross Margin plunged 2206 bps in 2022, then soared 2090 bps in 2026.
- Over 5 years, Gross Margin stood at 82.13% in 2022, then decreased by 9 bps to 74.53% in 2023, then decreased by 3 bps to 72.42% in 2024, then climbed by 21 bps to 87.77% in 2025, then decreased by 17 bps to 73.16% in 2026.
- The last three Gross Margin figures came in at 73.16% (Q2 2026), 87.85% (Q1 2026), and 87.77% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 45.84% |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | 73.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.16% |
| Mar 31, 2026 | 87.85% |
| Dec 31, 2025 | 87.77% |
| Sep 30, 2025 | 78.25% |
| Jun 30, 2025 | 67.65% |
| Mar 31, 2025 | 66.94% |
| Dec 31, 2024 | 72.42% |
| Sep 30, 2024 | 64.77% |
| Jun 30, 2024 | 73.00% |
| Mar 31, 2024 | 88.36% |
| Dec 31, 2023 | 74.53% |
| Sep 30, 2023 | 83.52% |
| Jun 30, 2023 | 73.62% |
| Mar 31, 2023 | 76.73% |
| Dec 31, 2022 | 82.13% |
| Sep 30, 2022 | 65.65% |
| Jun 30, 2022 | 70.30% |
| Mar 31, 2022 | 85.77% |
| Dec 31, 2021 | 104.19% |
| Sep 30, 2021 | 83.37% |